Ticker Scorecard - KOD Basics Company: Kodiak Sciences Inc IPO Date: October 1, 2018 Sector: Healthcare Industry: Biotech Market Cap: $303.64M Activated in VL: True Average Daily Range Avg Daily Range: $1.12 | 3.57% Avg Daily Range (30 D): $0.43 | 5.05% Avg Daily Range (90 D): $0.27 | 4.07% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .37M Avg Daily Volume (90 D): .33M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 85 Institutional Trades Total Inst.Trades: 1,205 Avg Inst. Trade: $2.36M Avg Inst. Trade (30 D): $1.84M Avg Inst. Trade (90 D): $1.22M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.83M Avg Closing Trade (30 D): $2.83M Avg Closing Trade (90 D): $1.62M Avg Closing Volume: 58.74K     News Jan 10, 2025 @ 2:35 PM Diabetic Retinopathy Global Clinical Trials Review... Source: Researchandmarkets.Com Jun 20, 2024 @ 12:23 PM Should You Hold Kodiak Sciences (KOD) Stock in You... Source: Zacks Equity Research Jun 14, 2024 @ 3:30 PM Why Is Kodiak Sciences (KOD) Down 26.2% Since Last... Source: Zacks Equity Research May 16, 2024 @ 4:51 PM Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipel... Source: Zacks Equity Research Apr 4, 2024 @ 4:09 PM Kodiak (KOD) Counts on Tarcocimab Program Despite ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-3.64 $-.84 $-.86 Diluted EPS $-3.64 $-.84 $-.86 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -191.62M $ -43.95M $ -45.12M Operating Income / Loss $ -204.04M $ -46.63M $ -47.98M Cost of Revenue $ $ $ Net Cash Flow $ -147.94M $ -21.36M $ -26.69M PE Ratio